Breast Cancer Clinical Trial
Study on Physical Activity’s Relationship With Cancer and Cognition
Summary
Aim 1: This pilot study tests the effects of aerobic exercise training on cognitive function in breast cancer survivors (BCS). To test aim 1, the investigators will randomize up to forty post-menopausal BCS (3-24 months post-treatment) to a 12-week walking intervention (n=20) or usual care (n=20). Walking participants will attend small group (n=3-5 BCS) sessions led by an exercise specialist 3 times weekly. Usual care participants will complete baseline and post-testing and be offered two sessions with an exercise specialist after all data have been collected. Aim 1 measures include accelerometry, neurocognitive testing, and patient-reported outcomes at baseline and post-intervention.
Aim 2: The investigators will generate preliminary data on clinical and biological correlates of exercise and cognition, including treatment protocol, cardiorespiratory fitness, brain structure and function, and cancer-related fatigue. To test aim 2, all participants will complete a fitness test, electrophysiology, and patient-reported outcomes at baseline and post-intervention. A subset of participants will also be invited to undergo magnetic resonance imaging (MRI).
Data will be analyzed using descriptive statistics and analysis of covariance, and effect sizes expressed as standard mean difference will be calculated.
Eligibility Criteria
Inclusion Criteria:
Female
Post-menopausal at time of diagnosis
First, primary diagnosis of Stage I-IIIa breast cancer
Completed treatment 3-24 months prior to study start
Available to attend exercise sessions 3 times weekly for 12 weeks
No scheduled travel >7 consecutive days during the intervention
Agree to be randomized
Willingness to wear, charge, and sync Fitbit
English reading and speaking
Physician's clearance to exercise
Provide written informed consent
Exclusion Criteria:
Males
Pre- or peri-menopausal at the time of diagnosis
Stage 0 or metastatic disease
Currently receiving chemotherapy or radiation therapy
More than 24 months post-treatment
Scheduled to receive breast surgery
Second cancer diagnosis (excluding non-invasive skin cancers)
Self-report an average of ≥60 minutes of MVPA per week for the previous 6 months
Not cleared to exercise by a physician
Not available to attend 3 times weekly exercise sessions for 12 weeks
Out of town travel scheduled for >1 week during the intervention
Unwilling to complete baseline assessments
Unwilling to be randomized to the exercise or control group
Unwilling to wear, charge, and sync the Fitbit during the study period
Unable to read and speak in English
Unwilling to provide written informed consent to participate
Cognitive impairment prior to baseline assessment
History of stroke, transient ischemic attack, other neurological disorders, or brain surgery involving tissue removal
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Omaha Nebraska, 68198, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.